Skip to content

Vericel VCEL Other Income (Expense)

Other Income (Expense) at other companies

Stryker logo
StrykerSYK
$62M-3.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$3M-203%
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$127K-6,450%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
$2.83M+379%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's other income (expense)?
Vericel (VCEL) reported other income (expense) of $1.76M in Q1 2026.
How has Vericel's other income (expense) changed year-over-year?
Vericel's other income (expense) increased by 14.0% year-over-year, from $1.55M to $1.76M.
What is the long-term trend for Vericel's other income (expense)?
Over 4 years (2021 to 2025), Vericel's other income (expense) has grown at a 119.7% compound annual growth rate (CAGR), from $272K to $6.33M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.